Medicines regulator approves first monoclonal antibody treatment for COVID-19 in UK

摘要

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance. To learn more about coronavirus, please visit:?https://www.rpharms.com/coronavirus (https://www.rpharms.com/coronavirus) The first monoclonal antibody (MAB) cocktail has been approved for use in the prevention and treatment of acute COVID-19 in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced.